[ASAP] Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00292

Source: Molecular Pharmaceutics - June 27, 2022 Category: Drugs & Pharmacology Authors: Daniel Porat, Oleg Dukhno, Ella Vainer, Sandra Cvijic ́, and Arik Dahan Source Type: research